Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03516591
Title A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amphivena Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Washington University, Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 42310 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field